Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 26Brain Neoplasms 23Lung Neoplasms 17Neoplasm Metastasis 15Breast Neoplasms 12Melanoma 9Carcinoma, Renal Cell 8Pancreatic Neoplasms 6Colorectal Neoplasms 6Carcinoma, Hepatocellular 4Urinary Bladder Neoplasms 3Neoplasms 3NSCLC 3Meningioma 3Gastrointestinal Neoplasms 3Unresectable Locally Recurrent Rectal Cancer 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Spinal Cord Compression 2Small Cell Lung Carcinoma 2Sarcoma 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Epidural Neoplasms 2Carcinoma, Transitional Cell 2Adenocarcinoma 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Interventions

pembrolizumab 6avelumab 6Nivolumab 5Specimen Handling 4Magnetic Resonance Spectroscopy 3Biopsy 3prednylidene 2lutetium Lu 177 dotatate 2deltacortene 2Prednisone 2Ipilimumab 2CTLA-4 Antigen 2talimogene laherparepvec 1lenvatinib 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1cemiplimab 1aldesleukin 1Tacrolimus 1Sirolimus 1Saline Solution 1Radiotherapy 1Radiosurgery 1MAPRE1 protein, human 1Lutetium-177 1Laparoscopy 1Exercise Test 1Cyclophosphamide 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Merkel Cell × Radiosurgery × 90 days × Clear all
NCT03304639 2026-05-13

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

National Cancer Institute (NCI)

Phase 2 Completed
9 enrolled 11 charts
Dermatologic

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡